<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37681886</PMID><DateCompleted><Year>2023</Year><Month>09</Month><Day>11</Day></DateCompleted><DateRevised><Year>2023</Year><Month>09</Month><Day>11</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2073-4409</ISSN><JournalIssue CitedMedium="Internet"><Volume>12</Volume><Issue>17</Issue><PubDate><Year>2023</Year><Month>Aug</Month><Day>27</Day></PubDate></JournalIssue><Title>Cells</Title><ISOAbbreviation>Cells</ISOAbbreviation></Journal><ArticleTitle>The Eye of the Storm: Investigating the Long-Term Cardiovascular Effects of COVID-19 and Variants.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">2154</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/cells12172154</ELocationID><Abstract><AbstractText>COVID-19 had stormed through the world in early March of 2019, and on 5 May 2023, SARS-CoV-2 was officially declared to no longer be a global health emergency. The rise of new COVID-19 variants <i>XBB.1.5</i> and <i>XBB.1.16</i>, a product of recombinant variants and sub-strains, has fueled a need for continued surveillance of the pandemic as they have been deemed increasingly infectious. Regardless of the severity of the variant, this has caused an increase in hospitalizations, a strain in resources, and a rise of concern for public health. In addition, there is a growing population of patients experiencing cardiovascular complications as a result of post-acute sequelae of COVID-19. This review aims to focus on what was known about SARS-CoV-2 and its past variants (Alpha, Delta, Omicron) and how the knowledge has grown today with new emerging variants, with an emphasis on cardiovascular complexities. We focus on the possible mechanisms that cause the observations of chronic cardiac conditions seen even after patients have recovered from the infection. Further understanding of these mechanisms will help to close the gap in knowledge on post-acute sequelae of COVID-19 and the differences between the effects of variants.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Vishwakarma</LastName><ForeName>Nandini</ForeName><Initials>N</Initials><Identifier Source="ORCID">0000-0002-3629-9791</Identifier><AffiliationInfo><Affiliation>Department of Physiology, Brody School of Medicine at East Carolina University, Greenville, NC 27834, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Goud</LastName><ForeName>Reshma B</ForeName><Initials>RB</Initials><AffiliationInfo><Affiliation>Department of Physiology, Brody School of Medicine at East Carolina University, Greenville, NC 27834, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tirupattur</LastName><ForeName>Myna Prakash</ForeName><Initials>MP</Initials><AffiliationInfo><Affiliation>Department of Physiology, Brody School of Medicine at East Carolina University, Greenville, NC 27834, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Katwa</LastName><ForeName>Laxmansa C</ForeName><Initials>LC</Initials><Identifier Source="ORCID">0000-0001-7479-4630</Identifier><AffiliationInfo><Affiliation>Department of Physiology, Brody School of Medicine at East Carolina University, Greenville, NC 27834, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>08</Month><Day>27</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Cells</MedlineTA><NlmUniqueID>101600052</NlmUniqueID><ISSNLinking>2073-4409</ISSNLinking></MedlineJournalInfo><SupplMeshList><SupplMeshName Type="Organism" UI="C000711908">SARS-CoV-2 variants</SupplMeshName></SupplMeshList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006321" MajorTopicYN="N">Heart</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002319" MajorTopicYN="Y">Cardiovascular System</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018450" MajorTopicYN="N">Disease Progression</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">acute cardiac injury</Keyword><Keyword MajorTopicYN="N">cardiovascular disease</Keyword><Keyword MajorTopicYN="N">long COVID</Keyword><Keyword MajorTopicYN="N">variants</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>7</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>8</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>8</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>9</Month><Day>11</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>9</Month><Day>8</Day><Hour>12</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>9</Month><Day>8</Day><Hour>8</Hour><Minute>54</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>8</Month><Day>27</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37681886</ArticleId><ArticleId IdType="pmc">PMC10486388</ArticleId><ArticleId IdType="doi">10.3390/cells12172154</ArticleId><ArticleId IdType="pii">cells12172154</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Tsao C.W., Aday A.W., Almarzooq Z.I., Anderson C.A., Arora P., Avery C.L., Baker-Smith C.M., Beaton A.Z., Boehme A.K., Buxton A.E., et al. Heart Disease and Stroke Statistics&#x2014;2023 Update: A Report From the American Heart Association. Circulation. 2023;147:e93&#x2013;e621. doi: 10.1161/CIR.0000000000001123.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIR.0000000000001123</ArticleId><ArticleId IdType="pubmed">36695182</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie Y., Xu E., Bowe B., Al-Aly Z. Long-term cardiovascular outcomes of COVID-19. Nat. Med. 2022;28:583&#x2013;590. doi: 10.1038/s41591-022-01689-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-01689-3</ArticleId><ArticleId IdType="pmc">PMC8938267</ArticleId><ArticleId IdType="pubmed">35132265</ArticleId></ArticleIdList></Reference><Reference><Citation>Hiscott J., Alexandridi M., Muscolini M., Tassone E., Palermo E., Soultsioti M., Zevini A. The global impact of the coronavirus pandemic. Cytokine Growth Factor Rev. 2020;53:1&#x2013;9. doi: 10.1016/j.cytogfr.2020.05.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cytogfr.2020.05.010</ArticleId><ArticleId IdType="pmc">PMC7254014</ArticleId><ArticleId IdType="pubmed">32487439</ArticleId></ArticleIdList></Reference><Reference><Citation>Greenberg G.C., Vishwakarma N., Tirupattur M.P., Sprague H.M., Katwa L.C. Implications of COVID-19 Pandemic on Pregnancy: Current Status and Controversies. COVID. 2023;3:859&#x2013;873. doi: 10.3390/covid3060062.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/covid3060062</ArticleId></ArticleIdList></Reference><Reference><Citation>El-Shabasy R.M., Nayel M.A., Taher M.M., Abdelmonem R., Shoueir K.R., Kenawy E.R. Three waves changes, new variant strains, and vaccination effect against COVID-19 pandemic. Int. J. Biol. Macromol. 2022;204:161&#x2013;168. doi: 10.1016/j.ijbiomac.2022.01.118.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijbiomac.2022.01.118</ArticleId><ArticleId IdType="pmc">PMC8782737</ArticleId><ArticleId IdType="pubmed">35074332</ArticleId></ArticleIdList></Reference><Reference><Citation>Katwa L.C., Mendoza C., Clements M. CVD and COVID-19: Emerging Roles of Cardiac Fibroblasts and Myofibroblasts. Cells. 2022;11:1316. doi: 10.3390/cells11081316.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells11081316</ArticleId><ArticleId IdType="pmc">PMC9031661</ArticleId><ArticleId IdType="pubmed">35455995</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao Y.-H., Zhao L., Yang X.-C., Wang P. Cardiovascular complications of SARS-CoV-2 infection (COVID-19): A systematic review and meta-analysis. Rev. Cardiovasc. Med. 2021;22:159. doi: 10.31083/j.rcm.2021.01.238.</Citation><ArticleIdList><ArticleId IdType="doi">10.31083/j.rcm.2021.01.238</ArticleId><ArticleId IdType="pubmed">33792257</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsai E.J., &#x10c;ih&#xe1;kov&#xe1; D., Tucker N.R. Cell-Specific Mechanisms in the Heart of COVID-19 Patients. Circ. Res. 2023;132:1290&#x2013;1301. doi: 10.1161/CIRCRESAHA.123.321876.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCRESAHA.123.321876</ArticleId><ArticleId IdType="pmc">PMC10171292</ArticleId><ArticleId IdType="pubmed">37167361</ArticleId></ArticleIdList></Reference><Reference><Citation>Bailey A.L., Dmytrenko O., Greenberg L., Bredemeyer A.L., Ma P., Liu J., Penna V., Winkler E.S., Sviben S., Brooks E., et al. SARS-CoV-2 Infects Human Engineered Heart Tissues and Models COVID-19 Myocarditis. JACC Basic Transl. Sci. 2021;6:331&#x2013;345. doi: 10.1016/j.jacbts.2021.01.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacbts.2021.01.002</ArticleId><ArticleId IdType="pmc">PMC7909907</ArticleId><ArticleId IdType="pubmed">33681537</ArticleId></ArticleIdList></Reference><Reference><Citation>Katwa L.C., Shashikant C. The Cardiac Fibroblast. Research Signpost; Kerala, India: 2011. Cardiac Remodeling and Fibrosis: Role of Myofibroblasts; pp. 29&#x2013;52.</Citation></Reference><Reference><Citation>CDC  SARS-CoV-2 Variant Classifications and Definitions. Center for Disease Control and Prevention. 11 February 2020.  [(accessed on 24 July 2023)]; Available online:  https://www.cdc.gov/coronavirus/2019-ncov/variants/variant-classifications.html#anchor_1679059484954.</Citation></Reference><Reference><Citation>CoVariants  CoVariants.org. 2023.  [(accessed on 16 July 2023)].  Available online:  https://covariants.org/</Citation></Reference><Reference><Citation>Molteni E., Graham M., Canas L.S., Antonelli M., Chen L., Deng J., Murray B., Kerfoot E., Wolf J., May A., et al. COVID-19 due to the B.1.617.2 (Delta) variant compared to B.1.1.7 (Alpha) variant of SARS-CoV-2: A prospective observational cohort study. Sci. Rep. 2022;12:10904. doi: 10.1038/s41598-022-14016-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-022-14016-0</ArticleId><ArticleId IdType="pmc">PMC9240087</ArticleId><ArticleId IdType="pubmed">35764879</ArticleId></ArticleIdList></Reference><Reference><Citation>Hern&#xe1;ndez-Aceituno A., Garc&#xed;a-Hern&#xe1;ndez A., Larumbe-Zabala E. COVID-19 long-term sequelae: Omicron versus Alpha and Delta variants. Infect. Dis. Now. 2023;53:104688. doi: 10.1016/j.idnow.2023.104688.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.idnow.2023.104688</ArticleId><ArticleId IdType="pmc">PMC9970656</ArticleId><ArticleId IdType="pubmed">36858287</ArticleId></ArticleIdList></Reference><Reference><Citation>Earnest R., Uddin R., Matluk N., Renzette N., Turbett S.E., Siddle K.J., Loreth C., Adams G., Tomkins-Tinch C.H., Petrone M.E., et al. Comparative transmissibility of SARS-CoV-2 variants Delta and Alpha in New England, USA. Cell Rep. Med. 2022;3:100583. doi: 10.1016/j.xcrm.2022.100583.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.xcrm.2022.100583</ArticleId><ArticleId IdType="pmc">PMC8913280</ArticleId><ArticleId IdType="pubmed">35480627</ArticleId></ArticleIdList></Reference><Reference><Citation>CDC  Understanding Risk. Center for Disease Control and Prevention. 11 February 2020.  [(accessed on 16 July 2023)]; Available online:  https://www.cdc.gov/coronavirus/2019-ncov/your-health/understanding-risk.html.</Citation></Reference><Reference><Citation>Augusto D.G., Murdolo L.D., Chatzileontiadou D.S.M., Sabatino J.J., Yusufali T., Peyser N.D., Butcher X., Kizer K., Guthrie K., Murray V.W., et al. A common allele of HLA is associated with asymptomatic SARS-CoV-2 infection. Nature. 2023;620:128&#x2013;136. doi: 10.1038/s41586-023-06331-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-023-06331-x</ArticleId><ArticleId IdType="pmc">PMC10396966</ArticleId><ArticleId IdType="pubmed">37468623</ArticleId></ArticleIdList></Reference><Reference><Citation>CDC  CDC Archives&#x2014;COVID Data. Center for Disease Control and Prevention.  [(accessed on 16 July 2023)];2023  Available online:  https://archive.cdc.gov/#/details?q=covid%2019%20hospitalization%20death%20rate%20&amp;start=0&amp;rows=10&amp;url=https://www.cdc.gov/coronavirus/2019-ncov/covid-data/investigations-discovery/hospitalization-death-by-age.html.</Citation></Reference><Reference><Citation>CDC  Symptoms of COVID-19. Center for Disease Control and Prevention. 11 February 2020.  [(accessed on 16 July 2023)]; Available online:  https://www.cdc.gov/coronavirus/2019-ncov/symptoms-testing/symptoms.html.</Citation></Reference><Reference><Citation>Tobler D.L., Pruzansky A.J., Naderi S., Ambrosy A.P., Slade J.J. Long-Term Cardiovascular Effects of COVID-19: Emerging Data Relevant to the Cardiovascular Clinician. Curr. Atheroscler. Rep. 2022;24:563&#x2013;570. doi: 10.1007/s11883-022-01032-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11883-022-01032-8</ArticleId><ArticleId IdType="pmc">PMC9065238</ArticleId><ArticleId IdType="pubmed">35507278</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou F., Yu T., Du R., Fan G., Liu Y., Liu Z., Xiang J., Wang Y., Song B., Gu X., et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: A retrospective cohort study. Lancet. 2020;395:1054&#x2013;1062. doi: 10.1016/S0140-6736(20)30566-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30566-3</ArticleId><ArticleId IdType="pmc">PMC7270627</ArticleId><ArticleId IdType="pubmed">32171076</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong J.Y., Cheung J.K., Lin Y., Bond H.S., Lau E.H.Y., Ip D.K.M., Cowling B.J., Wu P. Intrinsic and Effective Severity of Coronavirus Disease 2019 Cases Infected With the Ancestral Strain and Omicron BA.2 Variant in Hong Kong. J. Infect. Dis. 2023 doi: 10.1093/infdis/jiad236. ahead-of-print .</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiad236</ArticleId><ArticleId IdType="pubmed">37368235</ArticleId></ArticleIdList></Reference><Reference><Citation>Buchan S.A., Chung H., Brown K.A., Austin P.C., Fell D.B., Gubbay J.B., Nasreen S., Schwartz K.L., Sundaram M.E., Tadrous M., et al. Estimated Effectiveness of COVID-19 Vaccines Against Omicron or Delta Symptomatic Infection and Severe Outcomes. JAMA Netw. Open. 2022;5:e2232760. doi: 10.1001/jamanetworkopen.2022.32760.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2022.32760</ArticleId><ArticleId IdType="pmc">PMC9500552</ArticleId><ArticleId IdType="pubmed">36136332</ArticleId></ArticleIdList></Reference><Reference><Citation>Arabi M., Al-Najjar Y., Mhaimeed N., Salameh M.A., Paul P., AlAnni J., Abdelati A.A., Laswi I., Khanjar B., Al-Ali D., et al. Severity of the Omicron SARS-CoV-2 variant compared with the previous lineages: A systematic review. J. Cell. Mol. Med. 2023;27:1443&#x2013;1464. doi: 10.1111/jcmm.17747.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jcmm.17747</ArticleId><ArticleId IdType="pmc">PMC10243162</ArticleId><ArticleId IdType="pubmed">37203288</ArticleId></ArticleIdList></Reference><Reference><Citation>Lewnard J.A., Hong V.X., Patel M.M., Kahn R., Lipsitch M., Tartof S.Y. Clinical outcomes associated with SARS-CoV-2 Omicron (B.1.1.529) variant and BA.1/BA.1.1 or BA.2 subvariant infection in Southern California. Nat. Med. 2022;28:1933&#x2013;1943. doi: 10.1038/s41591-022-01887-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-01887-z</ArticleId><ArticleId IdType="pmc">PMC10208005</ArticleId><ArticleId IdType="pubmed">35675841</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang L., Berger N.A., Kaelber D.C., Davis P.B., Volkow N.D., Xu R. COVID infection rates, clinical outcomes, and racial/ethnic and gender disparities before and after Omicron emerged in the US. medRxiv. 2022 doi: 10.1101/2022.02.21.22271300.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2022.02.21.22271300</ArticleId></ArticleIdList></Reference><Reference><Citation>Antonelli M., Pujol J.C., Spector T.D., Ourselin S., Steves C.J. Risk of long COVID associated with delta versus omicron variants of SARS-CoV-2. Lancet. 2022;399:2263&#x2013;2264. doi: 10.1016/S0140-6736(22)00941-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(22)00941-2</ArticleId><ArticleId IdType="pmc">PMC9212672</ArticleId><ArticleId IdType="pubmed">35717982</ArticleId></ArticleIdList></Reference><Reference><Citation>Spinicci M., Graziani L., Tilli M., Nkurunziza J., Vellere I., Borchi B., Mencarini J., Campolmi I., Gori L., Giovannoni L., et al. Infection with SARS-CoV-2 Variants Is Associated with Different Long COVID Phenotypes. Viruses. 2022;14:2367. doi: 10.3390/v14112367.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v14112367</ArticleId><ArticleId IdType="pmc">PMC9698829</ArticleId><ArticleId IdType="pubmed">36366465</ArticleId></ArticleIdList></Reference><Reference><Citation>Del Prete A., Conway F., Della Rocca D.G., Biondi-Zoccai G., De Felice F., Musto C., Picich&#xe8; M., Martuscelli E., Natale A., Versaci F. COVID-19, Acute Myocardial Injury, and Infarction. Card. Electrophysiol. Clin. 2022;14:29&#x2013;39. doi: 10.1016/j.ccep.2021.10.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ccep.2021.10.004</ArticleId><ArticleId IdType="pmc">PMC8556597</ArticleId><ArticleId IdType="pubmed">35221083</ArticleId></ArticleIdList></Reference><Reference><Citation>Benhuri B., Aikawa T., Takagi H., Benhuri D., Kuno T. Elevated Natriuretic Peptides in Patients With Severe or Critical COVID-19: A Meta-Analysis. Tex. Heart Inst. J. 2022;49:e207404. doi: 10.14503/THIJ-20-7404.</Citation><ArticleIdList><ArticleId IdType="doi">10.14503/THIJ-20-7404</ArticleId><ArticleId IdType="pmc">PMC9632402</ArticleId><ArticleId IdType="pubmed">36223219</ArticleId></ArticleIdList></Reference><Reference><Citation>DePace N.L., Colombo J. Long-COVID Syndrome and the Cardiovascular System: A Review of Neurocardiologic Effects on Multiple Systems. Curr. Cardiol. Rep. 2022;24:1711&#x2013;1726. doi: 10.1007/s11886-022-01786-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11886-022-01786-2</ArticleId><ArticleId IdType="pmc">PMC9524329</ArticleId><ArticleId IdType="pubmed">36178611</ArticleId></ArticleIdList></Reference><Reference><Citation>Fishman B., Goitein O., Berkovitch A., Rahav G., Matetzky S. First report of myocarditis in two patients with COVID-19 Omicron variant: Case report. Eur. Heart J.&#x2014;Case Rep. 2022;6:ytac407. doi: 10.1093/ehjcr/ytac407.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ehjcr/ytac407</ArticleId><ArticleId IdType="pmc">PMC9581207</ArticleId><ArticleId IdType="pubmed">36285226</ArticleId></ArticleIdList></Reference><Reference><Citation>Saleh J., Peyssonnaux C., Singh K.K., Edeas M. Mitochondria and microbiota dysfunction in COVID-19 pathogenesis. Mitochondrion. 2020;54:1&#x2013;7. doi: 10.1016/j.mito.2020.06.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mito.2020.06.008</ArticleId><ArticleId IdType="pmc">PMC7837003</ArticleId><ArticleId IdType="pubmed">32574708</ArticleId></ArticleIdList></Reference><Reference><Citation>Xavier L.L., Neves P.F.R., Paz L.V., Neves L.T., Bagatini P.B., Timmers L.F.S.M., Rasia-Filho A.A., Mestriner R.G., Wieck A. Does Angiotensin II Peak in Response to SARS-CoV-2? Front. Immunol. 2021;11:577875. doi: 10.3389/fimmu.2020.577875.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2020.577875</ArticleId><ArticleId IdType="pmc">PMC7842149</ArticleId><ArticleId IdType="pubmed">33519802</ArticleId></ArticleIdList></Reference><Reference><Citation>Camargo R.L., Bombassaro B., Monfort-Pires M., Mansour E., Palma A.C., Ribeiro L.C., Ulaf R.G., Bernardes A.F., Nunes T.A., Agrela M.V., et al. Plasma Angiotensin II Is Increased in Critical Coronavirus Disease 2019. Front. Cardiovasc. Med. 2022;9:847809. doi: 10.3389/fcvm.2022.847809.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcvm.2022.847809</ArticleId><ArticleId IdType="pmc">PMC9263116</ArticleId><ArticleId IdType="pubmed">35811697</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu S.-W., Ilyas I., Weng J.-P. Endothelial dysfunction in COVID-19: An overview of evidence, biomarkers, mechanisms and potential therapies. Acta Pharmacol. Sin. 2023;44:695&#x2013;709. doi: 10.1038/s41401-022-00998-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41401-022-00998-0</ArticleId><ArticleId IdType="pmc">PMC9574180</ArticleId><ArticleId IdType="pubmed">36253560</ArticleId></ArticleIdList></Reference><Reference><Citation>Lemari&#xe9; C.A., Schiffrin E.L. The angiotensin II type 2 receptor in cardiovascular disease. J. Renin-Angiotensin-Aldosterone Syst. 2010;11:19&#x2013;31. doi: 10.1177/1470320309347785.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1470320309347785</ArticleId><ArticleId IdType="pubmed">19861349</ArticleId></ArticleIdList></Reference><Reference><Citation>WHO  . XBB.1.5 Rapid Risk Assessment, 11 January 2023. World Health Organization; Geneva, Switzerland: 2023.  [(accessed on 16 July 2023)].  Available online:  https://www.who.int/docs/default-source/coronaviruse/11jan2023_xbb15_rapid_risk_assessment.pdf.</Citation></Reference><Reference><Citation>WHO  . XBB.1.5 Updated Rapid Risk Assessment, 25 January 2023. World Health Organization; Geneva, Switzerland: 2023.  [(accessed on 16 July 2023)].  Available online:  https://www.who.int/docs/default-source/coronaviruse/25012023xbb.1.pdf?sfvrsn=c3956081_1.</Citation></Reference><Reference><Citation>WHO  . XBB.1.5 Updated Risk Assessment, 24 February 2023. World Health Organization; Geneva, Switzerland: 2023.  [(accessed on 16 July 2023)].  Available online:  https://www.who.int/docs/default-source/coronaviruse/22022024xbb.1.5ra.pdf.</Citation></Reference><Reference><Citation>Africa N.I.D.S. Tracking SARS-CoV-2 Variants. National Institute for Communicable Diseases. 2023.  [(accessed on 16 July 2023)].  Available online:  https://www.nicd.ac.za/wp-content/uploads/2023/02/Update-of-SA-sequencing-data-from-GISAID-17-Feb-2023_Final.pdf.</Citation></Reference><Reference><Citation>Iwu-Jaja C., Taukobong S., Rachida S., Ndlovu N., Macheke M., Howard W., Moonsamy S., Pocock G., Coetzee L., Mans J., et al.  Detection, Quantitation and Genomic Sequencing at Sentinel Sites in South Africa, Co-Funded by the Water Research Commission, the Bill and Melinda Gates Foundation and the NICD City of Cape Town Health Department Wastewater-Based Epidemiology for SARS-CoV-2 Surveillance in South Africa. 2021.  [(accessed on 16 July 2023)].  Available online:  https://www.nicd.ac.za/diseases-a-z-index/disease-</Citation></Reference><Reference><Citation>Yue C., Song W., Wang L., Jian F., Chen X., Gao F., Shen Z., Wang Y., Wang X., Cao Y. ACE2 binding and antibody evasion in enhanced transmissibility of XBB.1.5. Lancet Infect. Dis. 2023;23:278&#x2013;280. doi: 10.1016/S1473-3099(23)00010-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(23)00010-5</ArticleId><ArticleId IdType="pmc">PMC9897732</ArticleId><ArticleId IdType="pubmed">36746173</ArticleId></ArticleIdList></Reference><Reference><Citation>WHO . XBB.1.16 Updated Risk Assessment, 5 June 2023. World Health Organization; Geneva, Switzerland: 2023.</Citation></Reference><Reference><Citation>Karyakarte R.P., Das R., Rajmane M.V., Dudhate S., Agarasen J., Pillai P., Chandankhede P.M., Labhshetwar R.S., Gadiyal Y., Kulkarni P.P., et al. Chasing SARS-CoV-2 XBB.1.16 Recombinant Lineage in India and the Clinical Profile of XBB.1.16 Cases in Maharashtra, India. Cureus. 2023;15:e39816. doi: 10.7759/cureus.39816.</Citation><ArticleIdList><ArticleId IdType="doi">10.7759/cureus.39816</ArticleId><ArticleId IdType="pmc">PMC10314318</ArticleId><ArticleId IdType="pubmed">37397651</ArticleId></ArticleIdList></Reference><Reference><Citation>DeGrasse D.C., Black S.D. The Rise of SARS-CoV-2 (COVID-19) Omicron Subvariant Pathogenicity. Cureus. 2023;15:e40148. doi: 10.7759/cureus.40148.</Citation><ArticleIdList><ArticleId IdType="doi">10.7759/cureus.40148</ArticleId><ArticleId IdType="pmc">PMC10260278</ArticleId><ArticleId IdType="pubmed">37313287</ArticleId></ArticleIdList></Reference><Reference><Citation>WHO . Coronavirus Disease (COVID-19) Pandemic. World Health Organization; Geneva, Switzerland: 2023.</Citation></Reference><Reference><Citation>Patel K., Hipskind J.E.  StatPearls [Internet] National Center for Biotechnology Information; Bethesda, MD, USA: 2023.  [(accessed on 16 July 2023)]. Cardiac Arrest. Available online:  https://www.ncbi.nlm.nih.gov/books/NBK534866/</Citation></Reference><Reference><Citation>Chugh H.S., Sargsyan A., Nakamura K., Uy-Evanado A., Dizon B., Norby F.L., Young C., Hadduck K., Jui J., Shepherd D., et al. Sudden cardiac arrest during the COVID-19 pandemic: A two-year prospective evaluation in a North American community. HeartRhythm. 2023;20:947&#x2013;955. doi: 10.1016/j.hrthm.2023.03.025.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.hrthm.2023.03.025</ArticleId><ArticleId IdType="pmc">PMC10035806</ArticleId><ArticleId IdType="pubmed">36965652</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis H.E., McCorkell L., Vogel J.M., Topol E.J. Long COVID: Major findings, mechanisms and recommendations. Nat. Rev. Microbiol. 2023;21:133&#x2013;146. doi: 10.1038/s41579-022-00846-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-022-00846-2</ArticleId><ArticleId IdType="pmc">PMC9839201</ArticleId><ArticleId IdType="pubmed">36639608</ArticleId></ArticleIdList></Reference><Reference><Citation>Maitz T., Parfianowicz D., Vojtek A., Rajeswaran Y., Vyas A.V., Gupta R. COVID-19 Cardiovascular Connection: A Review of Cardiac Manifestations in COVID-19 Infection and Treatment Modalities. Curr. Probl. Cardiol. 2023;48:101186. doi: 10.1016/j.cpcardiol.2022.101186.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cpcardiol.2022.101186</ArticleId><ArticleId IdType="pmc">PMC8957382</ArticleId><ArticleId IdType="pubmed">35351486</ArticleId></ArticleIdList></Reference><Reference><Citation>Otifi H.M., Adiga B.K. Endothelial Dysfunction in COVID-19 Infection. Am. J. Med. Sci. 2022;363:281&#x2013;287. doi: 10.1016/j.amjms.2021.12.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjms.2021.12.010</ArticleId><ArticleId IdType="pmc">PMC8802031</ArticleId><ArticleId IdType="pubmed">35093394</ArticleId></ArticleIdList></Reference><Reference><Citation>Nappi F., Giacinto O., Ellouze O., Nenna A., Singh S.S.A., Chello M., Bouzguenda A., Copie X. Association between COVID-19 Diagnosis and Coronary Artery Thrombosis: A Narrative Review. Biomedicines. 2022;10:702. doi: 10.3390/biomedicines10030702.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biomedicines10030702</ArticleId><ArticleId IdType="pmc">PMC8945192</ArticleId><ArticleId IdType="pubmed">35327504</ArticleId></ArticleIdList></Reference><Reference><Citation>Rinaldi R., Basile M., Salzillo C., Grieco D.L., Caff&#xe8; A., Masciocchi C., Lilli L., Damiani A., La Vecchia G., Iannaccone G., et al. Myocardial Injury Portends a Higher Risk of Mortality and Long-Term Cardiovascular Sequelae after Hospital Discharge in COVID-19 Survivors. J. Clin. Med. 2022;11:5964. doi: 10.3390/jcm11195964.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm11195964</ArticleId><ArticleId IdType="pmc">PMC9573406</ArticleId><ArticleId IdType="pubmed">36233830</ArticleId></ArticleIdList></Reference><Reference><Citation>CDC  COVID-19: Medical Conditions. Center for Disease Control and Prevention May 2023.  [(accessed on 16 July 2023)]; Available online:  https://www.cdc.gov/coronavirus/2019-ncov/need-extra-precautions/people-with-medical-conditions.html.</Citation></Reference><Reference><Citation>Jayaraman R., Reinier K., Nair S., Aro A.L., Uy-Evanado A., Rusinaru C., Stecker E.C., Gunson K., Jui J., Chugh S.S., et al. Risk Factors of Sudden Cardiac Death in the Young. Circulation. 2018;137:1561&#x2013;1570. doi: 10.1161/CIRCULATIONAHA.117.031262.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.117.031262</ArticleId><ArticleId IdType="pmc">PMC5918307</ArticleId><ArticleId IdType="pubmed">29269388</ArticleId></ArticleIdList></Reference><Reference><Citation>Baldi E., Sechi G.M., Mare C., Canevari F., Brancaglione A., Primi R., Klersy C., Palo A., Contri E., Ronchi V., et al. Out-of-Hospital Cardiac Arrest during the COVID-19 Outbreak in Italy. N. Engl. J. Med. 2020;383:496&#x2013;498. doi: 10.1056/NEJMc2010418.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMc2010418</ArticleId><ArticleId IdType="pmc">PMC7204428</ArticleId><ArticleId IdType="pubmed">32348640</ArticleId></ArticleIdList></Reference><Reference><Citation>Hayek S.S., Brenner S.K., Azam T.U., Shadid H.R., Anderson E., Berlin H., Pan M., Meloche C., Feroz R., O&#x2019;hayer P., et al. In-hospital cardiac arrest in critically ill patients with COVID-19: Multicenter cohort study. BMJ. 2020;371:m3513. doi: 10.1136/bmj.m3513.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.m3513</ArticleId><ArticleId IdType="pmc">PMC7525342</ArticleId><ArticleId IdType="pubmed">32998872</ArticleId></ArticleIdList></Reference><Reference><Citation>Long COVID Terms and Definitions Development Explained. Department of Health and Human Services; Washington, DC, USA: 2023. COVID.org.</Citation></Reference><Reference><Citation>Lam I.C.H., Wong C.K.H., Zhang R., Chui C.S.L., Lai F.T.T., Li X., Chan E.W.Y., Luo H., Zhang Q., Man K.K.C., et al. Long-term post-acute sequelae of COVID-19 infection: A retrospective, multi-database cohort study in Hong Kong and the UK. EClinicalMedicine. 2023;60:102000. doi: 10.1016/j.eclinm.2023.102000.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2023.102000</ArticleId><ArticleId IdType="pmc">PMC10173760</ArticleId><ArticleId IdType="pubmed">37197226</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez-Leon S., Wegman-Ostrosky T., Perelman C., Sepulveda R., Rebolledo P.A., Cuapio A., Villapol S. More than 50 long-term effects of COVID-19: A systematic review and meta-analysis. Sci. Rep. 2021;11:16144. doi: 10.1038/s41598-021-95565-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-95565-8</ArticleId><ArticleId IdType="pmc">PMC8352980</ArticleId><ArticleId IdType="pubmed">34373540</ArticleId></ArticleIdList></Reference><Reference><Citation>Davido B., Seang S., Tubiana R., de Truchis P. Post&#x2013;COVID-19 chronic symptoms: A postinfectious entity? Clin. Microbiol. Infect. 2020;26:1448&#x2013;1449. doi: 10.1016/j.cmi.2020.07.028.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2020.07.028</ArticleId><ArticleId IdType="pmc">PMC7376333</ArticleId><ArticleId IdType="pubmed">32712242</ArticleId></ArticleIdList></Reference><Reference><Citation>Toori K.U., Qureshi M.A., Chaudhry A. Lymphopenia: A useful predictor of COVID-19 disease severity and mortality. Pak. J. Med. Sci. 2021;37:1984&#x2013;1988. doi: 10.12669/pjms.37.7.4085.</Citation><ArticleIdList><ArticleId IdType="doi">10.12669/pjms.37.7.4085</ArticleId><ArticleId IdType="pmc">PMC8613069</ArticleId><ArticleId IdType="pubmed">34912430</ArticleId></ArticleIdList></Reference><Reference><Citation>Alqahtani M.S., Abbas M., Alsabaani A., Alqarni A., Almohiy H.M., Alsawqaee E., Alshahrani R., Alshahrani S. The Potential Impact of COVID-19 Virus on the Heart and the Circulatory System. Infect. Drug Resist. 2022;2022:1175&#x2013;1189. doi: 10.2147/IDR.S351318.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/IDR.S351318</ArticleId><ArticleId IdType="pmc">PMC8957310</ArticleId><ArticleId IdType="pubmed">35345472</ArticleId></ArticleIdList></Reference><Reference><Citation>Raman B., Bluemke D.A., L&#xfc;scher T.F., Neubauer S. Long COVID: Post-acute sequelae of COVID-19 with a cardiovascular focus. Eur. Heart J. 2022;43:1157&#x2013;1172. doi: 10.1093/eurheartj/ehac031.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehac031</ArticleId><ArticleId IdType="pmc">PMC8903393</ArticleId><ArticleId IdType="pubmed">35176758</ArticleId></ArticleIdList></Reference><Reference><Citation>Puntmann V.O., Carerj M.L., Wieters I., Fahim M., Arendt C., Hoffmann J., Shchendrygina A., Escher F., Vasa-Nicotera M., Zeiher A.M., et al. Outcomes of Cardiovascular Magnetic Resonance Imaging in Patients Recently Recovered From Coronavirus Disease 2019 (COVID-19) JAMA Cardiol. 2020;5:1265. doi: 10.1001/jamacardio.2020.3557.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamacardio.2020.3557</ArticleId><ArticleId IdType="pmc">PMC7385689</ArticleId><ArticleId IdType="pubmed">32730619</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie Y., Choi T., Al-Aly Z. Association of Treatment With Nirmatrelvir and the Risk of Post&#x2013;COVID-19 Condition. JAMA Intern. Med. 2023;183:554&#x2013;564. doi: 10.1001/jamainternmed.2023.0743.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamainternmed.2023.0743</ArticleId><ArticleId IdType="pmc">PMC10037200</ArticleId><ArticleId IdType="pubmed">36951829</ArticleId></ArticleIdList></Reference><Reference><Citation>Novotn&#xe1; E., Filipov&#xe1; P., Vonke I., Kuta B., Chrdle A. Rapid Progression of COVID-19-Associated Fatal Capillary Leak Syndrome. Infect. Dis. Rep. 2022;14:884&#x2013;888. doi: 10.3390/idr14060088.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/idr14060088</ArticleId><ArticleId IdType="pmc">PMC9680370</ArticleId><ArticleId IdType="pubmed">36412746</ArticleId></ArticleIdList></Reference><Reference><Citation>Choi G.-J., Baek S.H., Kim J., Kim J.H., Kwon G.-Y., Kim D.K., Jung Y.H., Kim S. Fatal Systemic Capillary Leak Syndrome after SARS-CoV-2Vaccination in Patient with Multiple Myeloma. Emerg. Infect. Dis. 2021;27:2973&#x2013;2975. doi: 10.3201/eid2711.211723.</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid2711.211723</ArticleId><ArticleId IdType="pmc">PMC8544977</ArticleId><ArticleId IdType="pubmed">34459725</ArticleId></ArticleIdList></Reference><Reference><Citation>Bowe B., Xie Y., Al-Aly Z. Acute and postacute sequelae associated with SARS-CoV-2 reinfection. Nat. Med. 2022;28:2398&#x2013;2405. doi: 10.1038/s41591-022-02051-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-02051-3</ArticleId><ArticleId IdType="pmc">PMC9671810</ArticleId><ArticleId IdType="pubmed">36357676</ArticleId></ArticleIdList></Reference><Reference><Citation>CDC . Trends in Laboratory-Confirmed SARS-CoV-2 Reinfections and Associated Hospitalizations and Deaths Among Adults Aged &#x2265;18 Years&#x2014;18 U.S. Jurisdictions, September 2021&#x2013;December 2022. Center for Disease Control and Prevention; Atlanta, GA, USA: 2023.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10328471</ArticleId><ArticleId IdType="pubmed">37347715</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>